Problem 6 - Biochemistry

Question

Why are reduced glutathione levels in red blood cells dependent on the activity of the enzyme glucose-6-phosphate dehydrogenase? Why are individuals with a glucose-6-phosphate dehydrogenase deficiency sensitive to prophylactic antimalarials such as primaquine, but at the same time more resistant to developing malaria even without primaquine treatment?

Step-by-Step Solution

Answer

Answer: G6PD deficiency, which results in reduced glutathione levels in red blood cells, causes sensitivity to prophylactic antimalarials like primaquine due to an increased risk of hemolysis and related complications. However, it also provides resistance to malaria, as Plasmodium parasites struggle to thrive in G6PD deficient red blood cells.

Step 1: Understand the role of glucose-6-phosphate dehydrogenase enzyme in red blood cells

Glucose-6-phosphate dehydrogenase (G6PD) is an important enzyme that plays a role in the pentose phosphate pathway (PPP). This pathway is responsible for producing NADPH, which is required for the regeneration of reduced glutathione (GSH) in RBCs. GSH is a crucial antioxidant that helps protect RBCs from oxidative damage caused by reactive oxygen species (ROS).

Step 2: Explain the link between G6PD and reduced glutathione

G6PD catalyzes the conversion of glucose-6-phosphate (G6P) to 6-phosphogluconolactone in the first step of the pentose phosphate pathway. This reaction reduces NADP+ to NADPH in the process. NADPH is then utilized by glutathione reductase to convert oxidized glutathione (GSSG) back into reduced glutathione (GSH). Without G6PD, the production of NADPH is diminished, leading to a decreased capacity for regeneration of GSH. Lower GSH levels render RBCs more susceptible to oxidative stress and damage.

Step 3: Explain the sensitivity to prophylactic antimalarials in G6PD deficient individuals

Prophylactic antimalarial drugs, such as primaquine, generate ROS as part of their mode of action against malaria-causing Plasmodium parasites. However, these generated ROS can also cause oxidative stress and damage to RBCs. Individuals with G6PD deficiency have reduced GSH levels, making their RBCs more vulnerable to the oxidative stress induced by primaquine. Consequently, these individuals are at a higher risk of experiencing hemolysis (RBC destruction) and related complications when treated with primaquine.

Step 4: Explain the resistance to malaria in G6PD deficient individuals without primaquine

Interestingly, G6PD deficiency can also provide resistance to malaria, even in the absence of primaquine treatment. This is because the Plasmodium parasites rely on the host's G6PD activity for their growth and survival. When infecting G6PD deficient RBCs, the parasites encounter a diminished supply of NADPH, which impairs their ability to defend themselves against the oxidative stress generated by their own metabolism. As a result, Plasmodium parasites have lower survival rates inside G6PD deficient RBCs, providing the host with a degree of natural resistance against malaria infections. To summarize, reduced glutathione levels in RBCs depend on G6PD activity to maintain antioxidant defenses against oxidative stress. G6PD deficient individuals are sensitive to prophylactic antimalarials like primaquine due to the increased likelihood of hemolysis and associated complications; however, they also display a higher resistance to malaria even without primaquine treatment, as the Plasmodium parasites struggle to thrive within G6PD deficient RBCs.